次世代型シーケンシング (NGS) サービスの世界市場：市場機会の分析と産業予測
Next Generation Sequencing Services Market by Service Type, Technology, Application, and End User - Global Forecast to 2025
|発行||Meticulous Market Research Pvt. Ltd.||商品コード||619499|
|出版日||ページ情報||英文 193 Pages
|次世代型シーケンシング (NGS) サービスの世界市場：市場機会の分析と産業予測 Next Generation Sequencing Services Market by Service Type, Technology, Application, and End User - Global Forecast to 2025|
|出版日: 2019年10月18日||ページ情報: 英文 193 Pages||
当レポートでは、世界の次世代型シーケンシング (NGS) サービスの市場の成長見通しについて分析し、市場の基本構造や主な促進・抑制要因、全体的な市場動向見通し (過去3年間・今後6年間分)、サービスの種類別・用途別・エンドユーザー別・地域別の詳細動向、近年の市場競争・資本取引の動き、主要企業のプロファイルなどを調査しております。
Next Generation Sequencing Services Market by Service Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing) Technology (Sequencing by Synthesis, Nanopore, SMRT) Application (Clinical Diagnosis, Biomarker Discovery) & by End User - Forecast to 2025
The global next generation sequencing services market is expected to grow at a CAGR of 20.5% from 2019 to reach $13.1 billion by 2025. The growth in NGS services market is mainly attributed to the plummeting cost of sequencing, technological advancement in NGS services, and increase in genome mapping programs. In addition, increasing applications of NGS in cancer and agrigenomics research will further provide significant growth opportunities for the various stakeholders in this market. However, lack of skilled professionals for efficient NGS sample preparation and analysis, and high cost of sequencing infrastructure - are likely to hinder the market growth.
The overall NGS services market is mainly segmented by service type (targeted sequencing, RNA sequencing, exome sequencing, De Novosequencing, ChIP-sequencing, whole genome sequencing, methyl sequencing, and other services), technology (sequencing by synthesis, ion semiconductor, single molecule real time sequencing, nanopore sequencing, and true single molecule sequencing), application (diagnostics, drug discovery, biomarker discovery, agriculture and animal research, and other applications), end user (hospitals & clinics, pharmaceutical & biotechnology industry, academic & research institutes, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.
On the basis of service type, targeted sequencing segment is estimated to command the largest share of the overall NGS services market in 2019. The high share of targeted sequencing is mainly attributed to its ability to isolate and sequence fragment of genes or region. The increasing adoption of targeted sequencing has also led to its use in biomarker discovery, which is used to identify the clinically suitable targets in the field of translational research.
On the basis of technology, sequencing by synthesis commanded the largest share of the overall NGS services market in 2019. The large share of this segment is attributed to its high accuracy in DNA sequencing, highest yield of error-free throughput, and base call value of above Q30. However, Single Molecule Real Time (SMRT) sequencing technology is expected to grow at the fastest CAGR during the forecast period, owing to its rising adoption for understanding the kinetic information in various areas of research, including genomics, transcriptomics, and epigenetics.
On the basis of application, the diagnostics segment is estimated to command the largest share of the overall NGS services market in 2019. The large share of the diagnostics segment is primarily attributed to the significant use of NGS services for the treatment of cancer patients, globally; and improvement in NGS based oncology and Non-Invasive Prenatal Tests (NIPT).
An in-depth analysis of the geographical scenario of the NGS services market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global NGS services market in 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa.
The key players operating in the global NGS services market are Illumina, Inc. (U.S.), Qiagen N.V. (The Netherlands), PerkinElmer, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), Macrogen, Inc. (South Korea), Genotypic Technology Pvt. Ltd. (India), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd. (India), MedGenome (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Corporation (China), LGC Limited (U.K.), CD Genomics (U.S.), and SeqLL, LLC (U.S.).